Glioma News and Research

RSS

Glioma is a cancer of the brain that begins in glial cells (cells that surround and support nerve cells).

Study identifies specific genetic risk factors that increase susceptibility to gliomas

A massive new study involving blood samples from over 30,000 individuals has identified 13 new genetic risk factors for glioma, the most common type of malignant brain tumor in adults

29 Mar 2017

Antibody treats pediatric brain tumors safely and effectively in mice

Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.

15 Mar 2017

Study reveals promising new strategy to attack deadly pediatric brain tumor

Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.

7 Mar 2017

Danish researchers get closer to finding treatment for malignant cerebral tumour in children

DIPG (Diffuse Intrinsic Pontine Glioma) is a rare malignant cerebral tumour in children. It has only a 1% 5-year survival rate, amongst other things because it is not possible to operate because the tumour is located in the brain stem.

28 Feb 2017

New molecule may inhibit growth of aggressive pediatric brain tumor

Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor. The tumor is always fatal and primarily strikes children under 10 years old.

27 Feb 2017

Genomic analysis of brain tumor helps doctors keep cancer at bay for five years

An analysis of a patient's deadly brain tumor helped doctors at Smilow Cancer Hospital identify new emerging mutations and keep a 55-year old woman alive for more than five years, researchers report in the journal Genome Medicine.

17 Feb 2017

New study uncovers important links between glioblastoma and epileptic seizures

Detecting brain tumors at the earliest possible stage and eliminating them before seizures begin might be possible one day, according to research by scientists at Baylor College of Medicine and Texas Children's Hospital.

7 Feb 2017

Precision medicine advances diagnosis and treatment of children with brain tumors

Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.

20 Jan 2017

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

The National Comprehensive Cancer Network has published the NCCN Guidelines for Patients and NCCN Quick Guide sheets for Brain Cancer - Gliomas—the first in a series of patient education resources focused on Brain Cancer.

10 Jan 2017

New research suggests novel combination approach to fight against gliomas

"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.

4 Jan 2017

Researchers identify attractive drug candidate to target glioma tumors

In a paper published today in Cancer Research, researchers: 1) identify a biomarker enzyme associated with aggressive glioma brain tumors, 2) reveal the regulatory mechanism for that enzyme, and 3) demonstrate potent efficacy, using a mouse model of glioma, for a small molecule inhibitor they have developed.

16 Dec 2016

Scientists discover new biomarker to help determine aggressiveness of brain cancer

Researchers at UT Southwestern Medical Center have found a new biomarker for glioma, a common type of brain cancer, that can help doctors determine how aggressive a cancer is and that could eventually help determine the best course of treatment.

6 Dec 2016

Ancient Japanese art inspires groundbreaking technique to create ‘artificial brains’

The ancient Japanese art of flower arranging was the inspiration for a groundbreaking technique to create tiny "artificial brains" that could be used to develop personalized cancer treatments.

6 Dec 2016

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Children that are diagnosed with the severe the brain tumour malignant glioma often have a very poor prognosis. Knowledge about how pediatric malignant glioma arises and develops is still limited.

17 Nov 2016

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.

17 Nov 2016

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer.

17 Nov 2016

Deficiency of tumor suppressor gene may allow brain cancer cells to survive outside niches

Astronauts survive in space by wearing high-tech space suits. But how do brain cancer cells thrive when they migrate to inhospitable sites within the brain?

14 Nov 2016

Consortium develops new approach to understand causes of common cancers

Through the development of a novel, inexpensive genotyping microarray, the OncoArray, Dartmouth investigators have led a key collaborative research study that will revolutionize our knowledge of the causes of common cancers.

27 Oct 2016

Researchers develop MRI-based method that can track progression of genetically mutated gliomas

UT Southwestern Medical Center researchers have developed an MRI-based method that can track the state and progression of a common type of genetically mutated brain cancer.

17 Oct 2016

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Glioma News and Research

Further Reading

Study identifies specific genetic risk factors that increase susceptibility to gliomas

Antibody treats pediatric brain tumors safely and effectively in mice

Study reveals promising new strategy to attack deadly pediatric brain tumor

Danish researchers get closer to finding treatment for malignant cerebral tumour in children

New molecule may inhibit growth of aggressive pediatric brain tumor

Genomic analysis of brain tumor helps doctors keep cancer at bay for five years

New study uncovers important links between glioblastoma and epileptic seizures

Precision medicine advances diagnosis and treatment of children with brain tumors

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

New research suggests novel combination approach to fight against gliomas

Researchers identify attractive drug candidate to target glioma tumors

Scientists discover new biomarker to help determine aggressiveness of brain cancer

Ancient Japanese art inspires groundbreaking technique to create ‘artificial brains’

Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

Deficiency of tumor suppressor gene may allow brain cancer cells to survive outside niches

Consortium develops new approach to understand causes of common cancers

Researchers develop MRI-based method that can track progression of genetically mutated gliomas

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News